SLIT reduced TNSS, TMS, VAS scores, IL‐4, IL‐17, eosinophilia percentage (EOS%), and specific immunoglobulin E (sIgE) levels, while increasing INF‐γ, IL‐10, and sIgG4. The gene discussed is IL17A; the disease is Increased total eosinophil count.